Oruka Therapeutics GAAP EPS of -$0.55 misses by $0.01 (NASDAQ:ORKA)
· seekingalpha.com
Oruka Therapeutics press release (ORKA): Q2 GAAP EPS of -$0.55 misses by $0.01. As of June 30, 2026, Oruka had cash, cash equivalents and marketable securities
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...